After four days of cultivation, we assessed Tregs’ suppressive activity under the conditions described above, finding that the anti-CD3, IL-7, IL-15, and anti-CD3 + IL-2 stimulations had similar effects on the Treg suppressive activity for the CD4+ cells in the healthy donors and RA patients. The gene discussed is IL2; the disease is rheumatoid arthritis.